Bon Natural Life Ltd., a leading bio-ingredient solutions provider, has announced a non-exclusive sales distribution agreement with Beijing Huahai Keyuan Technology Co., Ltd., a prominent wellness company in China. The agreement, valued at up to $16 million, spans 24 months and involves the marketing, sale, and distribution of Bon's natural prebiotic series products in the Chinese market. This collaboration is seen as a significant step forward in the gut health sector, featuring a cutting-edge "Prebiotic + Postbiotic" complex with the flagship active ingredient, super prebiotic stachyose. Bon anticipates this strategic partnership will accelerate its entry into China's rapidly growing gut health market, driving substantial growth opportunities for both companies.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。